Management of complications of Dupuytren contracture

Kevin Cheung; Kempland C Walley; Tamara D Rozental

doi:10.1016/j.hcl.2015.01.005

Management of complications of Dupuytren contracture

Hand Clin. 2015 May;31(2):345-54. doi: 10.1016/j.hcl.2015.01.005.

Authors

Kevin Cheung¹, Kempland C Walley², Tamara D Rozental³

Affiliations

¹ Division of Plastic Surgery, Harvard Medical School, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, ST 10, Boston, MA 02215, USA.
² Department of Orthopedics, Harvard Medical School, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, ST 10, Boston, MA 02215, USA.
³ Department of Orthopedics, Harvard Medical School, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, ST 10, Boston, MA 02215, USA. Electronic address: trozenta@bidmc.harvard.edu.

PMID: 25934208
DOI: 10.1016/j.hcl.2015.01.005

Abstract

This evidence-based article discusses the current management options of Dupuytren disease and strategies to avoid and manage any potential complications. Treatment options include fasciectomy, needle fasciotomy/aponeurotomy, and collagenase injection. Complications include digital nerve and artery injury, flexor tendon injury, skin fissures and wound healing complications, hematoma, infection, flare reaction/complex regional pain syndrome, and recurrence. Complication rates, prevention, and management differ with each treatment modality. A detailed understanding of each of these options allows hand surgeons to select the most appropriate treatment for each patient.

Keywords: Collagenase injection; Complications; Dupuytren disease; Fasciectomy; Management; Needle aponeurotomy; Recurrence.

Publication types

Review

MeSH terms

Dupuytren Contracture / complications*
Dupuytren Contracture / physiopathology
Dupuytren Contracture / therapy*
Humans
Postoperative Complications / diagnosis
Postoperative Complications / therapy*